Duggingen, Switzerland

Stefan Abrecht

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Stefan Abrecht from Duggingen, CH

Introduction:

Stefan Abrecht, a talented inventor hailing from Duggingen, CH, has made significant contributions to the field of pharmaceuticals with a total of 5 patents to his name. His innovative work has sparked advancements in the treatment and prevention of diseases associated with DPP IV.

Latest Patents:

1. **Process for the preparation of pyrido[2,1-a] isoquinoline derivatives**: Stefan's patented process focuses on the creation of pyrido[2,1-a]isoquinoline derivatives, crucial compounds for combating diseases linked to DPP IV. These derivatives offer promising therapeutic benefits and open new avenues in the pharmaceutical industry.

2. **Salt and polymorphs of a DPPIV inhibitor**: Another groundbreaking invention by Stefan is (S)-1-{[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile mesylate and its crystalline polymorphs. These compounds exhibit superior properties compared to existing alternatives and hold immense potential as a medicinal solution for DPP-IV related disorders.

Career Highlights:

Stefan Abrecht is a distinguished member of the research team at Hoffmann-La Roche Inc., a renowned pharmaceutical company known for its cutting-edge innovations. His expertise and dedication have played a pivotal role in shaping the company's success and establishing it as a leader in the healthcare industry.

Collaborations:

Throughout his career, Stefan has collaborated closely with esteemed colleagues such as Jean-Michel Adam and Alec Fettes. Together, they have engaged in collaborative research, shared insights, and collectively contributed to the development of new and impactful pharmaceutical solutions.

Conclusion:

In conclusion, Stefan Abrecht's remarkable ingenuity and unwavering commitment to scientific excellence have left an indelible mark on the field of pharmaceuticals. His pioneering inventions not only enhance our understanding of DPP-IV related diseases but also offer hope for a healthier future. Stefan's collaborative spirit and innovative mindset continue to inspire breakthroughs that shape the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…